Frontlight ResearchEarly access
Trial site
WIP Warsaw IBD Point Profesor Kierkus
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis5 trials
- Crohn's disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Phase
- Phase 24 trials
- Phase 32 trials
- Phase 2/31 trial
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Bristol-Myers Squibb1 trial
- Landos Biopharma Inc.1 trial
- OSE Immunotherapeutics1 trial
- Pfizer1 trial
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026